UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 1, 2005
ENGELHARD CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 1-8142 22-1586002
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation) File Number) Identification No.)
101 Wood Avenue, Iselin, New Jersey 08830
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (732) 205-5000
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On March 1, 2005, Engelhard Corporation issued a press release reporting that it
has made an offer to acquire a majority stake in Coletica, S.A. A copy of the
press release is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits
The following are filed as exhibits to this report:
99.1 Press Release dated March 1, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ENGELHARD CORPORATION
--------------------------------
(Registrant)
Date: March 1, 2005 /s/ Michael A. Sperduto
--------------------------------- --------------------------------
Name: Michael A. Sperduto
Title: Vice President and
Chief Financial Officer
Exhibit 99.1
Contact
Ted Lowen
(Media)
732-205-6360
Gavin A. Bell
(Investor Relations)
732-205-6313
Ref. #C1407
Engelhard Corporation
101 Wood Avenue, P.O. Box 770
For immediate release Iselin, NJ 08830-0770
ENGELHARD OFFERS TO
ACQUIRE COLETICA, S.A.
ISELIN, NJ, March 1, 2005 - Engelhard Corporation (NYSE: EC) announced today
that it has made an offer, subject to certain conditions, to acquire a majority
stake in Coletica, S.A., a publicly traded, high-growth company that develops
performance-based, skin-care compounds and related technologies for the cosmetic
and personal care industries.
The acquisition would further strengthen Engelhard's position as a leading
global supplier of materials technology to the cosmetic and personal care
industries. It would expand the company's existing capabilities in the growing
market for skin-care materials used in such applications as anti-wrinkle creams,
sun protectants, moisturizers and materials that improve the overall complexion
of the skin.
"We continue to broaden our competencies in surface and materials science
and expand our portfolio of applications and markets served by our growing
personal care materials business," said Barry W. Perry, Engelhard's chairman and
chief executive officer. "This acquisition would be modestly accretive to
earnings, provide positive cash flow from operations and would be consistent
with our objective to improve our business mix."
If approval is granted, Engelhard would purchase 77.87% of Coletica's
outstanding shares held by a group led by Coletica's founder and president.
Engelhard then would make a tender offer for the remaining publicly held
shares at a price of (euro)37.10 per share. The offer translates into a purchase
price of (euro)65.85 million for 100% ownership.
Coletica was started in 1985 in Lyon, France. As part of the proposed
transaction, Engelhard would acquire the company's two facilities in Lyon, sales
offices in Paris, New York and Tokyo and its more than 120 employees.
Coletica has a portfolio of catalogue products that offer the global
skin-care market the substantiated performance that drives new product
development for their customers. In addition, Coletica develops specific
ingredients for its customers on an exclusive basis using its library of more
than 2,500 active ingredients and employs in-vitro testing to substantiate
claims for its customers' consumer products.
Engelhard's expertise in materials technology positions the company as a
leading supplier to the cosmetic and personal care industries. In addition to
its broad product offering, full-spectrum testing and product-development
services, Engelhard also provides a complete line of effect and color-enhancing
pigments as well as specialized inorganic materials for cosmetic and personal
care products. The company's effect pigments and special-effect films also
deliver eye-catching properties to the packaging of cosmetic and personal care
products.
Engelhard Corporation is a surface and materials science company that
develops technologies to help customers improve their products and processes. A
Fortune 500 company, Engelhard is a world-leading provider of technologies for
environmental, process, appearance and performance applications. For more
information, visit Engelhard on the Internet at www.engelhard.com
# # #
2